However, the study did not provide data on efficacy of the Novavax COVID-19 vaccine in preventing severe disease or hospitalization.
Novavax vaccine shows 51% efficacy in COVID-19 infections caused by B.1.351 variant
However, the study did not provide data on efficacy of the Novavax COVID-19 vaccine in preventing severe disease or hospitalization.